RNTX

Rein Therapeutics Inc (RNTX)

US
$ 1.914.37%

Price Chart

Key Statistics

Market Cap
$ 52.86M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
61.98K
52W High
$ 4.40
52W Low
$ 1.35
Dividend Yield
0.00%
Beta
2.23

Technicals

50-Day MA
2.1474
200-Day MA
2.8742
52 Week High
4.4
52 Week Low
1.35

About RNTX

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States.

Employees
11
Headquarters
Austin, TX
CEO
Dr. James Brian Windsor Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
PLRZ
Polyrizon Ltd. Ordi...
$ 1.24
389.38
KIDZ
Classover Holdings ...
$ 9.17
71.09
FRGT
Freight Technologie...
$ 1.63
65.52
IBO
IBO (Listing Market...
$ 0.60
50.10
CPS
Cooper-Standard Hol...
$ 20.48
34.56

Top Losers

Symbol/Name
LTP
% Chg
ZCAR
Zoomcar Holdings In...
$ 7.57
-42.54
PDEX
Pro-Dex Inc. Common...
$ 45.86
-31.86
XYZ
Block Inc. Class A ...
$ 46.43
-20.61
NVNI
Nvni Group Limited ...
$ 0.33
-19.68
FUBO
fuboTV Inc. Common ...
$ 2.43
-17.06